Danielle Benedict Sacdalan

495 total citations
26 papers, 350 citations indexed

About

Danielle Benedict Sacdalan is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Danielle Benedict Sacdalan has authored 26 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Economics and Econometrics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Danielle Benedict Sacdalan's work include Economic and Financial Impacts of Cancer (7 papers), COVID-19 and healthcare impacts (4 papers) and Lung Cancer Research Studies (3 papers). Danielle Benedict Sacdalan is often cited by papers focused on Economic and Financial Impacts of Cancer (7 papers), COVID-19 and healthcare impacts (4 papers) and Lung Cancer Research Studies (3 papers). Danielle Benedict Sacdalan collaborates with scholars based in Philippines, Canada and Switzerland. Danielle Benedict Sacdalan's co-authors include Josephine Anne Lucero, Dennis L. Sacdalan, Benjamin H. Lok, Cecilia Jimeno, Ming‐Sound Tsao, Mayou Martin T. Tampo, Reynaldo L. Garcia, Marie Dione Sacdalan, Jennifer Sandoval-Tan and Sabine Schmid and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Danielle Benedict Sacdalan

25 papers receiving 339 citations

Peers

Danielle Benedict Sacdalan
Kim Ryan Australia
Dennis L. Sacdalan Philippines
Débora S. Bruno United States
Rawad Elias United States
Ryan Huey United States
Danielle Benedict Sacdalan
Citations per year, relative to Danielle Benedict Sacdalan Danielle Benedict Sacdalan (= 1×) peers Maxime Frélaut

Countries citing papers authored by Danielle Benedict Sacdalan

Since Specialization
Citations

This map shows the geographic impact of Danielle Benedict Sacdalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Benedict Sacdalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Benedict Sacdalan more than expected).

Fields of papers citing papers by Danielle Benedict Sacdalan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Benedict Sacdalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Benedict Sacdalan. The network helps show where Danielle Benedict Sacdalan may publish in the future.

Co-authorship network of co-authors of Danielle Benedict Sacdalan

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Benedict Sacdalan. A scholar is included among the top collaborators of Danielle Benedict Sacdalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Benedict Sacdalan. Danielle Benedict Sacdalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sacdalan, Danielle Benedict, et al.. (2024). Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications. Current Oncology. 31(1). 482–500. 9 indexed citations
2.
Sacdalan, Danielle Benedict, et al.. (2022). O15-4 Use of virtual reality for management of anxiety and depression among chemotherapy-naive Filipino breast cancer patients. Annals of Oncology. 33. S478–S478. 2 indexed citations
3.
Sacdalan, Danielle Benedict, et al.. (2022). Choosing Wisely Philippines: ten low-value or harmful practices that should be avoided in cancer care. ecancermedicalscience. 16. 1424–1424. 3 indexed citations
4.
Schmid, Sabine, Katrina Hueniken, Danielle Benedict Sacdalan, et al.. (2022). Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. iScience. 25(12). 105487–105487. 11 indexed citations
5.
Sacdalan, Danielle Benedict & Josephine Anne Lucero. (2021). Revisiting a lower starting dose of alectinib in ALK-Positive non-small cell lung cancer. Cancer Treatment and Research Communications. 27. 100319–100319. 6 indexed citations
6.
Sacdalan, Danielle Benedict & Josephine Anne Lucero. (2021). The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development. OncoTargets and Therapy. Volume 14. 2053–2064. 16 indexed citations
7.
Sacdalan, Danielle Benedict, et al.. (2021). The role of the medical oncologist in the holistic care of patients with cancer in the Philippines. ecancermedicalscience. 15. ed115–ed115. 4 indexed citations
8.
Sacdalan, Danielle Benedict, et al.. (2021). A systematic review and meta-analysis on the efficacy and safety of metformin as adjunctive therapy among women with metastatic breast cancer. Cancer Treatment and Research Communications. 29. 100457–100457. 7 indexed citations
9.
Sacdalan, Dennis L., et al.. (2021). Clinicopathologic Factors Associated with Mismatch Repair Status Among Filipino Patients with Young-Onset Colorectal Cancer. Cancer Management and Research. Volume 13. 2105–2115. 5 indexed citations
10.
Sacdalan, Danielle Benedict, et al.. (2020). Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma. Medical Oncology. 37(11). 106–106. 4 indexed citations
11.
Sacdalan, Danielle Benedict, et al.. (2020). COVID-19 in cancer patients can be challenging to screen in a resource limited setting. Cancer Treatment and Research Communications. 25. 100214–100214. 2 indexed citations
13.
Sacdalan, Danielle Benedict, et al.. (2020). Treatment of cancer patients during the COVID-19 pandemic in the Philippines. ecancermedicalscience. 14. 1040–1040. 11 indexed citations
14.
Sacdalan, Danielle Benedict, et al.. (2020). Updated general recommendations in cancer management during the COVID-19 pandemic in the Philippines. ecancermedicalscience. 14. 1128–1128. 2 indexed citations
16.
Sacdalan, Danielle Benedict, et al.. (2020). Fan-on-Face Therapy in Relieving Dyspnea of Adult Terminally Ill Cancer Patients: A Meta-Analysis. SHILAP Revista de lepidopterología. 6. 88–93. 7 indexed citations
17.
Sacdalan, Danielle Benedict, et al.. (2020). Giant cell tumor of soft tissue of the nasopharynx: A case report. Cancer Treatment and Research Communications. 23. 100171–100171. 3 indexed citations
18.
Tampo, Mayou Martin T., et al.. (2020). 93P Assessment of nutritional status of colorectal cancer patients in a tertiary government hospital. Annals of Oncology. 31. S1278–S1278. 1 indexed citations
19.
Sacdalan, Danielle Benedict, et al.. (2019). Prognostic value of C-reactive protein, albumin and C-reactive protein to albumin ratio in small cell lung cancer: A meta-analysis. Annals of Oncology. 30. ix178–ix178. 3 indexed citations
20.
Sacdalan, Danielle Benedict, Josephine Anne Lucero, & Dennis L. Sacdalan. (2018). Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis. OncoTargets and Therapy. Volume 11. 955–965. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026